Evidence map›Paper›PMID 35325372›Full record

ReviewLa Radiologia medica2022

Radiomics-based prediction of two-year clinical outcome in locally advanced cervical cancer patients undergoing neoadjuvant chemoradiotherapy.

Rosa Autorino, Benedetta Gui, Giulia Panza, Luca Boldrini, Davide Cusumano, Luca Russo, Alessia Nardangeli, Salvatore Persiani, Maura Campitelli, Gabriella Ferrandina and 4 more

Registry-linked trialOpen access · hybridAbstract readReview
In one paragraph

Review in La Radiologia medica, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07305727 (Developing a Radiomic MRI Model Predictive of Response to Concomitant Chemoradiotherapy in Locally Advanced Cervical Cancer. A Prognostic, Retrospective, Open-label, Multicenter, Descriptive and Analytical Clinical Cohort Study), which is not on this map. Cited by 41 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed, 2 pooled it
6.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07305727 recruitingnot on this mapstarted 2026, after this paper: background citation

Developing a Radiomic MRI Model Predictive of Response to Concomitant Chemoradiotherapy in Locally Advanced Cervical Cancer. A Prognostic, Retrospective, Open-label, Multicenter, Descriptive and Analytical Clinical Cohort Study

TypeobservationalSponsorCentre Hospitalier Universitaire de NīmesRan2026 to 2026Enrolled120ConditionsUterine Cervical Neoplasms, Cervical Cancer by FIGO Stage 2018
3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 2 syntheses or guidelines pooled it, 48 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 2 countries.

Rosa AutorinoFondazione Policlinico Universitario "Agostino Gemelli" IRCCS, 00168, Roma, Italy.
Benedetta GuiFondazione Policlinico Universitario "Agostino Gemelli" IRCCS, 00168, Roma, Italy.
Giulia PanzaUniversità Cattolica del Sacro Cuore, Largo Francesco Vito, 1, 00168, Roma, Italy. giuliapnz91@gmail.com.ORCID http://orcid.org/0000-0002-4669-0436
Luca BoldriniFondazione Policlinico Universitario "Agostino Gemelli" IRCCS, 00168, Roma, Italy.
Davide CusumanoFondazione Policlinico Universitario "Agostino Gemelli" IRCCS, 00168, Roma, Italy.
Luca RussoFondazione Policlinico Universitario "Agostino Gemelli" IRCCS, 00168, Roma, Italy.
Alessia NardangeliFondazione Policlinico Universitario "Agostino Gemelli" IRCCS, 00168, Roma, Italy.
Salvatore PersianiUniversità Cattolica del Sacro Cuore, Largo Francesco Vito, 1, 00168, Roma, Italy.
Maura CampitelliFondazione Policlinico Universitario "Agostino Gemelli" IRCCS, 00168, Roma, Italy.
Gabriella FerrandinaFondazione Policlinico Universitario "Agostino Gemelli" IRCCS, 00168, Roma, Italy.
Gabriella MacchiaGemelli Molise Hospital, Università Cattolica del Sacro Cuore, Campobasso, Italy.
Vincenzo ValentiniFondazione Policlinico Universitario "Agostino Gemelli" IRCCS, 00168, Roma, Italy.
Maria Antonietta GambacortaFondazione Policlinico Universitario "Agostino Gemelli" IRCCS, 00168, Roma, Italy.
Riccardo ManfrediFondazione Policlinico Universitario "Agostino Gemelli" IRCCS, 00168, Roma, Italy.
Agostino Gemelli University Polyclinic · ITUniversità Cattolica del Sacro Cuore · ITCambia · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe aim of this study is to determine if radiomics features extracted from staging magnetic resonance (MR) images could predict 2-year long-term clinical outcome in patients with locally advanced cervical cancer (LACC) after neoadjuvant chemoradiotherapy (NACRT). MATERIALS AND

methodsWe retrospectively enrolled patients with LACC diagnosis who underwent NACRT followed by radical surgery in two different institutions. Radiomics features were extracted from pre-treatment 1.5 T T2w MR images. The predictive performance of each feature was quantified in terms of Wilcoxon-Mann-Whitney test. Among the significant features, Pearson correlation coefficient (PCC) was calculated to quantify the correlation among the different predictors. A logistic regression model was calculated considering the two most significant features at the univariate analysis showing the lowest PCC value. The predictive performance of the model created was quantified out using the area under the receiver operating characteristic curve (AUC).

resultsA total of 175 patients were retrospectively enrolled (142 for the training cohort and 33 for the validation one). 1896 radiomic feature were extracted, 91 of which showed significance (p < 0.05) at the univariate analysis. The radiomic model showing the highest predictive value combined the features calculated starting from the gray level co-occurrence-based features. This model achieved an AUC of 0.73 in the training set and 0.91 in the validation set.

conclusionsThe proposed radiomic model showed promising performances in predicting 2-year overall survival before NACRT. Nevertheless, the observed results should be tested in larger studies with consistent external validation cohorts, to confirm their potential clinical use.

Indexed as

Neoadjuvant TherapyUterine Cervical NeoplasmsChemoradiotherapyFemaleHumansMagnetic Resonance ImagingRetrospective StudiesROC CurveCervix uteriMagnetic resonanceNeoadjuvant chemotherapyPersonalized medicinePredictive medicineRadiomics

Identifiers

PMID35325372
PMCPMC9098600
OpenAlexW4221061108

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.